These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6216344

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Oral administration of a new carbenicillin in the treatment of urinary tract infection.
    Bailey RR, Koutsaimanis KG.
    Br J Urol; 1972 Apr; 44(2):235-9. PubMed ID: 4557443
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC, Gavan TL, Gerlach EH, Jones RN, Barry AL, Thornsberry C.
    Am J Med Sci; 1977 Apr; 274(3):255-63. PubMed ID: 610415
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Carbenicillin. Current data on its use].
    Bertoye A, Woehrle R.
    Lyon Med; 1971 Apr; 225():Suppl:137-41. PubMed ID: 5564793
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE, Høiby N.
    Scand J Infect Dis Suppl; 1981 Apr; 29():87-91. PubMed ID: 6458884
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Treatment of urinary tract infections with a massive dose of carbenicillin (CB-PC)].
    Kondo K, Amano M, Niijima T.
    Jpn J Antibiot; 1972 Jun; 25(3):175-80. PubMed ID: 4539550
    [No Abstract] [Full Text] [Related]

  • 54. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Human pharmacology and clinical evaluation of an oral carbenicillin preparation.
    Bran JL, Karl DM, Kaye D.
    Clin Pharmacol Ther; 1971 Nov; 12(3):525-30. PubMed ID: 5208911
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P.
    Presse Med; 1984 Mar 29; 13(13):830-3. PubMed ID: 6231606
    [Abstract] [Full Text] [Related]

  • 60. Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.
    Nishiura T.
    Clin Ther; 1980 Mar 29; 3(Spec Issue):190-205. PubMed ID: 6446394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.